BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1741058)

  • 1. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene.
    Pepin MC; Pothier F; Barden N
    Nature; 1992 Feb; 355(6362):725-8. PubMed ID: 1741058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression.
    Pepin MC; Pothier F; Barden N
    Mol Pharmacol; 1992 Dec; 42(6):991-5. PubMed ID: 1480137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited brain diffusion of the glucocorticoid receptor agonist RU28362 following i.c.v. administration: implications for i.c.v. drug delivery and glucocorticoid negative feedback in the hypothalamic-pituitary-adrenal axis.
    Francis AB; Pace TW; Ginsberg AB; Rubin BA; Spencer RL
    Neuroscience; 2006 Sep; 141(3):1503-15. PubMed ID: 16806720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of corticosteroid receptor gene expression in depression and antidepressant action.
    Barden N
    J Psychiatry Neurosci; 1999 Jan; 24(1):25-39. PubMed ID: 9987205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of imipramine and phenelzine on corticosteroid receptor gene expression in mouse brain: potential relevance to antidepressant response.
    Heydendael W; Jacobson L
    Brain Res; 2008 Oct; 1238():93-107. PubMed ID: 18761333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased hypothalamic and adrenal angiotensin II receptor expression and adrenomedullary catecholamines in transgenic mice with impaired glucocorticoid receptor function.
    Jain P; Armando I; Juorio AV; Barden N; Benicky J; Saavedra JM
    Neuroendocrinology; 2004; 80(3):171-80. PubMed ID: 15583474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging and the hypothalamus-pituitary-adrenocortical axis, with special reference to the dog.
    Rothuizen J; Reul JM; Rijnberk A; Mol JA; de Kloet ER
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():73-6. PubMed ID: 1801505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of steroid receptor function by gene targeting in mice.
    Wintermantel TM; Berger S; Greiner EF; Schütz G
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):107-12. PubMed ID: 15860252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term adaptations in glucocorticoid receptor and mineralocorticoid receptor mRNA and negative feedback on the hypothalamo-pituitary-adrenal axis following neonatal maternal separation.
    Ladd CO; Huot RL; Thrivikraman KV; Nemeroff CB; Plotsky PM
    Biol Psychiatry; 2004 Feb; 55(4):367-75. PubMed ID: 14960289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ontogeny of gender-specific responsiveness to stress and glucocorticoids in the rat and its determination by the neonatal gonadal steroid environment.
    Patchev VK; Hayashi S; Orikasa C; Almeida OF
    Stress; 1999 Aug; 3(1):41-54. PubMed ID: 19016192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasticity and function of brain corticosteroid receptors during aging.
    De Kloet ER; Sutanto W; Rots N; van Haarst A; van den Berg D; Oitzl M; van Eekelen A; Voorhuis D
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():65-72. PubMed ID: 1801504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the glucocorticoid receptor antagonist Org 34850 on basal and stress-induced corticosterone secretion.
    Spiga F; Harrison LR; Wood SA; Atkinson HC; MacSweeney CP; Thomson F; Craighead M; Grassie M; Lightman SL
    J Neuroendocrinol; 2007 Nov; 19(11):891-900. PubMed ID: 17927667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety.
    Tronche F; Kellendonk C; Kretz O; Gass P; Anlag K; Orban PC; Bock R; Klein R; Schütz G
    Nat Genet; 1999 Sep; 23(1):99-103. PubMed ID: 10471508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased glucocorticoid receptor activity following glucocorticoid receptor antisense RNA gene fragment transfection.
    Pepin MC; Barden N
    Mol Cell Biol; 1991 Mar; 11(3):1647-53. PubMed ID: 1996114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress.
    McEwen BS; Gould EA; Sakai RR
    Br J Psychiatry Suppl; 1992 Feb; (15):18-23. PubMed ID: 1389022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid receptors in the central nervous system of the rat.
    Stark E; Acs Z; Palkovits M; Folly G
    Acta Physiol Acad Sci Hung; 1975; 46(2):115-24. PubMed ID: 1235229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor.
    Stec I; Barden N; Reul JM; Holsboer F
    J Psychiatr Res; 1994; 28(1):1-5. PubMed ID: 8064637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noradrenergic regulation of type-I and type-II corticosteroid receptors in amygdala and hypothalamus.
    Maccari S; Piazza PV; Rouge-Pont F; Angelucci L; Simon H; le Moal M
    Brain Res; 1992 Aug; 587(2):313-8. PubMed ID: 1525664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditioned activity to amphetamine in transgenic mice expressing an antisense RNA against the glucocorticoid receptor.
    Steckler T; Holsboer F
    Behav Neurosci; 2001 Feb; 115(1):207-19. PubMed ID: 11256444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in glucocorticoid receptor binding and mRNA levels in the rat brain and pituitary.
    Peiffer A; Barden N; Meaney MJ
    Neurobiol Aging; 1991; 12(5):475-9. PubMed ID: 1770983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.